Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city. MIAMI, Nov. 9, 2017—Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, has added Aesthetic Polyclinic to its worldwide regenerative medicine network, naming it the exclusive
ISSCA and Global Stem Cells Group to Sponsor the XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery and Obesity Nov. 30 – Dec. 3, 2017, in Mexico City
The International Society for Stem Cell Application (ISSCA), and Global Stem Cells Group (GSCG) will sponsor the XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery Obesity. ISSCA and GSCG will launch their new online regenerative medicine training course, and will also launch a new adipose stem cell isolation
ISSCA to Conduct Regenerative Medicine Certification Training for Physicians in Buenos Aires, Argentina November 26 – 27, 2017
The International Association for Stem Cell Application (ISSCA) will be conducting a regenerative medicine certification course for physicians in Buenos Aires Nov. 26-27, 2017. The two-day intensive training course teaches trainees extraction, isolation, and application of PRP, adipose, and bone marrow stem cells. MIAMI, Nov. 9, 2017— The
The International Association for Stem Cell Application (ISSCA) has announced plans to host three regenerative medicine symposiums in Istanbul, Turkey, Buenos Aires, Argentina, and Seoul, Korea in 2018. The Seoul symposium will be part of, the 6th Annual International Conference of ISSCA, “Progress and Perspectives,” which will be held in Seoul in November 2018.
The Language of Stem Cell Medicine: What are They? What Makes Them so Special? And What do all Those Acronyms Mean?
Stem cell medicine is based on the concept that physicians can harness the body’s own reserves to heal itself, rather than relying exclusively on drugs or invasive surgical procedures. Stem cell medicine works by deals engineering human stem cells to replace or restore damaged or diseased organs or tissue, or establish normal function in them. While
Joseph Purita, M.D. Global Stem Cells Group Advisory Board member Joseph Purita, M.D., is a world-renowned orthopedic surgeon and stem cell pioneer, using cutting edge technology in regenerative medicine in conjunction with stem cell platelet rich plasma (PRP) therapy to treat orthopedic injuries and relieve pain. He is also a pioneer in the use of the